Genome & Company Market Cap

Genome & Company has a market cap or net worth of 84.09 billion as of August 14, 2025. Its market cap has decreased by -33.96% in one year.

Market Cap

84.09B

Enterprise Value

90.07B

Revenue

29.84B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,705.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 84.09B, an increase of 16.98%. That is a compound annual growth rate of 2.39%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	84.09B	-1.32%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	464.86T
SK hynix	185.70T
LG Energy Solution	90.91T
Samsung Biologics	72.67T
Hyundai Motor Company	46.56T
Hanwha Aerospace	43.78T
Doosan Enerbility	41.95T
KB Financial Group	41.04T

Market Cap Rankings